László Virág
Impact in
- Physiology top 0.2%
- Nitric Oxide and Endothelin Effects
- Adenosine and Purinergic Signaling
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
Papers in
- Oncology 45
- PARP inhibition in cancer therapy 40
- Physiology 13
- Nitric Oxide and Endothelin Effects 14
- Adenosine and Purinergic Signaling 13
- Co-authors
- Csaba Szabó (61 shared papers)Andrew L. Salzman (19 shared papers)Éva Szabó (33 shared papers)György Haskó (26 shared papers)Péter Bai (33 shared papers)Pál Gergely (22 shared papers)Jon G. Mabley (15 shared papers)Lucas Liaudet (13 shared papers)
- Journals
- Free Radical Biology and Medicine (9 papers)Redox Biology (7 papers)International Journal of Molecular Sciences (6 papers)The FASEB Journal (6 papers)The Journal of Immunology (6 papers)
- Partner nations
- HungaryUnited StatesPoland
In The Last Decade
László Virág
146 papers receiving 10.7k citations
László Virág's Hit Papers
Peers
Comparison fields: 5 of 126
- Physiology 798
- Geriatrics and Gerontology 355
- Oncology 1.9k
- Physiology 1.3k
- Neurology 388
Countries citing papers authored by László Virág
This map shows the geographic impact of László Virág's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Virág with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Virág more than expected).
Fields of papers citing papers by László Virág
This network shows the impact of papers produced by László Virág. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Virág. The network helps show where László Virág may publish in the future.
Co-authors
The 25 scholars most cited alongside László Virág, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Hit paper breakdown → | 2002 | 1234 |
| 2 | 2001 | 533 | |
| 3 | 2003 | 412 | |
| 4 | 2019 | 319 | |
| 5 | 2000 | 302 | |
| 6 | 1999 | 260 | |
| 7 | 2003 | 252 | |
| 8 | 2013 | 242 | |
| 9 | 2001 | 240 | |
| 10 | 1998 | 238 | |
| 11 | 1998 | 228 | |
| 12 | 1998 | 221 | |
| 13 | 1998 | 196 | |
| 14 | 2007 | 181 | |
| 15 | 2002 | 179 | |
| 16 | 2000 | 177 | |
| 17 | 2002 | 169 | |
| 18 | 2013 | 169 | |
| 19 | 1998 | 167 | |
| 20 | 2002 | 166 |
About László Virág
László Virág is a scholar working on Oncology, Physiology, Immunology, Molecular Biology and Physiology, having authored 150 papers that have together received 11.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (40 papers), Cell death mechanisms and regulation (23 papers), Redox biology and oxidative stress (17 papers), Nitric Oxide and Endothelin Effects (14 papers), Adenosine and Purinergic Signaling (13 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers), Immune Response and Inflammation (8 papers) and DNA Repair Mechanisms (7 papers). The work is most often cited by research in Physiology (798 citations), Geriatrics and Gerontology (355 citations), Oncology (1.9k citations), Physiology (1.3k citations) and Neurology (388 citations). László Virág has collaborated with scholars based in Hungary, United States and Poland. Frequent co-authors include Csaba Szabó, Andrew L. Salzman, Éva Szabó, György Haskó, Péter Bai, Pál Gergely, Jon G. Mabley, Lucas Liaudet, Francisco García Soriano and Pál Pacher. Their work appears in journals such as Free Radical Biology and Medicine, Redox Biology, International Journal of Molecular Sciences, The FASEB Journal and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.